With a growing commitment in the pharma world to data transparency, we require an innovative technology-driven solution using newly developed digital tools to make data and document sharing solutions achievable, scalable, and cost-effective. Metadata analytical algorithms will be used for de-identification and anonymization of data. This will ensure a greater control of the quality and reduction in overall process time.
* Presented by: Helle-Mai Gawrylewski, Sr. Director Regulatory Medical Writing, Janssen R&D. Titusville, NJ, USA * Supported by: Arghya Chattopadhyay, Vice President, Biostatistics and Statistical Programming, Tata Consultancy Services
